Genes and functional GI disorders: From casual to causal relationship

Neurogastroenterology and Motility

Volumn 25, Issue 8, 2013, Pages 638-649

  D'Amato, Mauro ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CHOLECYSTOKININ; FIBROBLAST GROWTH FACTOR RECEPTOR 4; GAMMA INTERFERON; GHRELIN; INTERLEUKIN 17; INTERLEUKIN 6; PEPTIDE YY; SEROTONIN; SEROTONIN RECEPTOR; TOLL LIKE RECEPTOR 9; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLELE; AUTOIMMUNE DISEASE; BONE DENSITY; CLINICAL CLASSIFICATION; CLINICAL FEATURE; CONSTIPATION; CROHN DISEASE; DENDRITIC CELL; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOPHENOTYPE; ENTERITIS; GASTROENTERITIS; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HEALTH CARE; HUMAN; HUNTINGTON CHOREA; INTESTINE FLORA; IRRITABLE COLON; MENTAL STRESS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLARTHRITIS; T LYMPHOCYTE; TH17 CELL; ULCERATIVE COLITIS;

ANIMALS; GASTROINTESTINAL DISEASES; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IRRITABLE BOWEL SYNDROME;

EID: 84880122146     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12173     Document Type: Review

References (63)

1. Lewis T. Reflections upon reform in medical education. Lancet 1944; 243: 619-21.
2. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130: 1377-90.
3. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653-4.
4. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
5. Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med 2013; 368: 578-9.
6. Camilleri M. Mechanisms in IBS: something old, something new, something borrowed. Neurogastroenterol Motil 2005; 17: 311-6.
7. Churchill A, Graw J. Clinical and experimental advances in congenital and paediatric cataracts. Philos Trans R Soc Lond B Biol Sci 2011; 366: 1234-49.
8. Klein C, Chuang R, Marras C, Lang AE. The curious case of phenocopies in families with genetic Parkinson's disease. Mov Disord 2011; 26: 1793-802.
9. Wild EJ, Tabrizi SJ. Huntington's disease phenocopy syndromes. Curr Opin Neurol 2007; 20: 681-7.
10. Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 2012; 11: 754-65.
11. Gottesman II, Shields J. Genetic theorizing and schizophrenia. Br J Psychiatry 1973; 122: 15-30.
12. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-45.
13. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum Genet 2012; 90: 7-24.
14. Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012; 302: G1075-84.
15. Zinsmeister AR, Burton D, Camilleri M. Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations. Dig Dis Sci 2013; 58: 509-18.
16. Saito YA. The role of genetics in IBS. Gastroenterol Clin North Am 2011; 40: 45-67.
17. Saito YA, Mitra N, Mayer EA. Genetic approaches to functional gastrointestinal disorders. Gastroenterology 2010; 138: 1276-85.
18. Camilleri M. Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes 2009; 16: 53-9.
19. Yamazaki K, McGovern D, Ragoussis J et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 2005; 14: 3499-506.
20. Zhang FR, Huang W, Chen SM et al. Genomewide association study of leprosy. N Engl J Med 2009; 361: 2609-18.
21. Jostins L, Ripke S, Weersma RK et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-24.
22. Zinovieva E, Bourgain C, Kadi A et al. Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis. PLoS Genet 2009; 5: e1000528.
23. Croft M. The role of TNF superfamily members in T-cell function and diseases. Nat Rev Immunol 2009; 9: 271-85.
24. Meylan F, Davidson TS, Kahle E et al. The TNF-family receptor DR3 is essential for diverse T cell-mediated inflammatory diseases. Immunity 2008; 29: 79-89.
25. Pappu BP, Borodovsky A, Zheng TS et al. TL1A-DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease. J Exp Med 2008; 205: 1049-62.
26. Shih DQ, Kwan LY, Chavez V et al. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur J Immunol 2009; 39: 3239-50.
27. Ohman L, Simrén M. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 2010; 7: 163-73.
28. Simrén M, Barbara G, Flint HJ et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62: 159-76.
29. Zucchelli M, Camilleri M, Andreasson AN et al. Association of TNFSF15 polymorphism with irritable bowel syndrome. Gut 2011; 60: 1671-7.
30. Swan C, Duroudier NP, Campbell E et al. Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα. Gut 2013; 62: 985-94.
31. Michelsen KS, Thomas LS, Taylor KD et al. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein. PLoS ONE 2009; 4: e4719.
32. Kakuta Y, Ueki N, Kinouchi Y et al. TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells. Hum Mol Genet 2009; 18: 1089-98.
33. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10: 735-42.
34. Heyes MP, Saito K, Crowley JS et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. Brain 1992; 115(Pt 5): 1249-73.
35. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-88.
36. Villani AC, Lemire M, Thabane M et al. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology 2010; 138: 1502-13.
37. Villani AC, Saito YA, Lemire M et al. Validation of genetic risk factors for post-infectious irritable bowel syndrome (IBS) in patients with sporadic IBS. Gastroenterology 2009; 136(5 Suppl. 1): 289.
38. Camilleri M, Carlson P, McKinzie S et al. Genetic susceptibility to inflammation and colonic transit in lower functional gastrointestinal disorders: preliminary analysis. Neurogastroenterol Motil 2011; 23: 935-e398.
39. Camilleri M, Atanasova E, Carlson PJ et al. Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndrome. Gastroenterology 2002; 123: 425-32.
40. Saito YA, Larson JJ, Atkinson EJ et al. The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci 2012; 57: 2650-7.
41. Yeo A, Boyd P, Lumsden S et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004; 53: 1452-8.
42. Kim HJ, Camilleri M, Carlson PJ et al. Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004; 53: 829-37.
43. Kapeller J, Houghton LA, Mönnikes H et al. First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet 2008; 17: 2967-77.
44. Camilleri M, Carlson P, Zinsmeister AR et al. Neuropeptide S receptor induces neuropeptide expression and associated with intermediate phenotypes of functional gastrointestinal disorders. Gastroenterology 2010; 138: 98-107.
45. Wong BS, Camilleri M, Carlson PJ et al. A Klothoβ variant mediates protein stability and associates with colon transit in irritable bowel syndrome with diarrhea. Gastroenterology 2011; 140: 1934-42.
46. Pape HC, Jüngling K, Seidenbecher T, Lesting J, Reinscheid RK. Neuropeptide S: a transmitter system in the brain regulating fear and anxiety. Neuropharmacology 2010; 58: 29-34.
47. Laitinen T, Polvi A, Rydman P et al. Characterization of a common susceptibility locus for asthma-related traits. Science 2004; 304: 300-4.
48. D'Amato M, Zucchelli M, Seddighzadeh M et al. Analysis of neuropeptide S receptor gene (NPSR1) polymorphism in rheumatoid arthritis. PLoS ONE 2010; 5: e9315.
49. D'Amato M, Bruce S, Bresso F et al. Neuropeptide s receptor 1 gene polymorphism is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2007; 133: 808-17.
50. Donner J, Haapakoski R, Ezer S et al. Assessment of the neuropeptide S system in anxiety disorders. Biol Psychiatry 2010; 68: 474-83.
51. Han RW, Chang M, Peng YL et al. Central Neuropeptide S inhibits distal colonic transit through activation of central Neuropeptide S receptor in mice. Peptides 2009; 30: 1313-7.
52. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JRF, Andreyev HJN. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30: 707-17.
53. Chiang JYL. Bile acids: regulation of synthesis. J Lipid Res 2009; 50: 1955-66.
54. Fukudo S, Kanazawa M, Mizuno T et al. Impact of serotonin transporter gene polymorphism on brain activation by colorectal distention. NeuroImage 2009; 47: 946-51.
55. Kilpatrick LA, Labus JS, Coveleskie K et al. The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome. Gastroenterology 2011; 140: 1943-51.
56. Quince C, Lundin EE, Andreasson AN et al. The impact of Crohn's disease genes on healthy human gut microbiota: a pilot study. Gut 2013; 62: 952-4.
57. Rausch P, Rehman A, Künzel S et al. Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci U S A 2011; 108: 19030-5.
58. Rehman A, Sina C, Gavrilova O et al. Nod2 is essential for temporal development of intestinal microbial communities. Gut 2011; 60: 1354-62.
59. Jeffrey IB, O'Toole PW, Öhman L et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 62: 159-76.
60. Size matters, and other lessons from medical genetics "Genomes Unzipped". Available at: http://www.genomesunzipped.org/2011/11/size-matters-and-other-lessons-from-medical-genetics.php (accessed 8 March 2013).
61. Chen R, Mias GI, Li-Pook-Than J et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012; 148: 1293-307.
62. Sullivan PF, Daly MJ, O'Donovan M. Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 2012; 13: 537-51.
63. Degen LP, Phillips SF. How well does stool form reflect colonic transit? Gut 1996; 39: 109-13.